Zimmer Biomet Holdings, Inc. (NYSE: ZBH)

Zimmer Biomet Holdings, Inc. is a global medical technology company that designs manufactures and markets products for musculoskeletal health. The company focuses on orthopedic reconstructive implants sports medicine biologics extremities trauma craniomaxillofacial and thoracic devices bone cement surgical tools and integrated digital and robotic platforms. It works with healthcare professionals worldwide to improve patient mobility and quality of life.

Zimmer Biomet Holdings Inc. generates revenue primarily through the sale of its orthopedic and related medical devices. Its product portfolio includes knee and hip replacement systems sports medicine and soft tissue repair products biologics extremities and trauma offerings craniomaxillofacial and thoracic implants bone cement surgical instruments and a suite of digital robotic and data analytics solutions. The company sells these products to orthopedic surgeons neurosurgeons hospitals ambulatory surgery centers stocking distributors healthcare dealers and group purchasing organizations. Revenue is recognized when title transfers to the customer either upon shipment or under consignment arrangements where inventory remains under the companys title until used in a procedure.

Zimmer Biomet Holdings Inc. holds a leading position in the global orthopedics market alongside major competitors such as Johnson Johnson MedTech Stryker Corporation and Smith Nephew plc. The companys competitive advantages stem from its broad and integrated product suite its investment in research and development and its strong global distribution network. Its ability to offer combined surgical robotic and digital technologies through the ZBEdge platform further differentiates it from peers. Continuous innovation in materials implant design and surface technologies supports its market standing.

Zimmer Biomet Holdings Inc. serves a diverse customer base that includes orthopedic surgeons neurosurgeons hospitals ambulatory surgery centers and other specialist physicians. It also sells through stocking distributors healthcare dealers and group purchasing organizations that act as buying agents for healthcare institutions. No single customer accounted for more than two percent of net sales in the most recent fiscal year indicating a widely diversified client base.